TIVENIX

Changing the way neurological disorders are diagnosed

We decode the epigenetic signature of Alzheimer’s disease in plasma with the power of machine learning. We aim at providing accurate and non-invasive diagnosis of neurodegenerative diseases, as well as monitor their progression and response to treatment.

TIVENIX

AI-powered diagnostic platform

Tivenix’s proprietary software diagnostic can analyse and interpret complex epigenetic patterns in plasma with accuracy matching current best clinical practice for AD diagnostics. Our platform is engineered to easily integrate with data from other biomarkers.

TIVENIX

Our science is based on a solid biological rationale and supported by clinical evidence

We can detect and characterize neuronal loss in blood samples. Our proof-of-concept study demonstrated the accuracy of our biomarker for Alzheimer’s disease. We are now conducting a confirmatory study to validate our results and expand our scope to other neurodegenerative diseases.

TIVENIX

Our people

We are a Swiss company with a team of experts in neuroscience, biotechnology, data science, and software engineering. We are committed to innovation, excellence, and social impact. We believe that our technology can make a difference in the fight against Alzheimer’s disease and improve the lives of millions of people around the world.

Board of Directors

Luca Soncini

Chairman

Paolo Paganetti

Board member

Luca Bolzani

Board member

Luca Soncini

Chairman

Luca is a seasoned executive and advisor in the financial sector, with expertise in corporate governance, M&A, and banking strategies. He is also a lecturer and an active supporter of neuroscience research.

Paolo Paganetti

Board member

Paolo is a biochemist and neuroscientist with a track record of discovering and developing drugs and diagnostics for Alzheimer’s disease and other neurodegenerative disorders. He is also a coordinator and professor at leading research institutions in Switzerland.

Luca Bolzani

Board member

Luca is a seasoned leader and investor in the pharma industry, with a background in organic chemistry and a history of growing and exiting successful companies. He is also the chairman of Fondazione Agire, a foundation that supports innovation and entrepreneurship.

Management team

Luca Colnaghi

Advisor

Giancarlo Faglia

Advisor

Maurizio Callari

Advisor

Ansgar Felbecker

Advisor

Leonardo Sacco

Advisor

Luca Colnaghi

Advisor

Luca is a biotech entrepreneur and molecular biologist with a Ph.D. from NYU and a background in functional genomics and bioinformatics. He is an assistant professor at San Raffaele University, where he investigates the role of ubiquitin proteins in AD and he has also co-founded several biotech startup.

Giancarlo Faglia

Advisor

With engineering and finance background, Giancarlo has been a manager and investor across diverse sectors. He has held senior positions in pharma companies, and currently serves as a board member of Sintetica and a senior manager of Swix Family Office.

Maurizio Callari

Advisor

Ansgar Felbecker

Advisor

Leonardo Sacco

Advisor

TIVENIX

News

Novembre 2023

Miro Venturi joins Tivenix’s Board of Directors

We are thrilled to announce that Miro Venturi has joined Tivenix SA as a board member! Miro brings a wealth of experience and expertise to our team, and we’re incredibly excited to have him on board. His strategic vision and

Ottobre 2023

Tivenix has been selected to participate in the Innosuisse Core Coaching program.

This is a significant milestone in our journey, as it will provide us with valuable support and guidance to further enhance our product and business. It also marks a motivating second endorsement of our hard work, building on the innovation

TIVENIX

Contact Us

We are looking for business partners that share our vision and want to collaborate in developing our platform.

If you are interested in learning more about our platform, our company, or our vision, please contact us.

We would love to hear from you and collaborate with you.